Inhibition of MERS-CoV papain-like protease by sunitinib: In vitro and in silico investigations
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) remains a significant public health threat, with high mortality rates and no approved antiviral therapies. The papain-like protease (PLpro) of MERS-CoV plays a critical role in viral replication and immune evasion, making it a key target for dr...
Saved in:
| Main Authors: | Ahmed L. Alaofi, Mudassar Shahid, Mohd Abul Kalam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2025-04-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/141634/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statine-based peptidomimetics as SARS-CoV-2 Papain-like protease inhibitors: in Silico and in vitro studies
by: Raiane Dandara Pereira Pimentel, et al.
Published: (2025-07-01) -
In Silico and In Vitro Inhibitory Activity of Indonesian Herbal Compound Extracts against SARS-COV-2 Recombinant Papain-Like Protease
by: Fairuz Andini Fatiningtyas, et al.
Published: (2024-12-01) -
Flavonoids Derived from the Roots of <i>Lespedeza bicolor</i> Inhibit the Activity of SARS-CoV Papain-like Protease
by: Hyun Sim Woo, et al.
Published: (2024-11-01) -
High-throughput screening of dual-target inhibitors for SARS-CoV-2 main protease and papain-like protease from Chebulae Fructus: in silico prediction and experimental verification
by: Changjian Wang, et al.
Published: (2024-12-01) -
Identification of naturally occurring drug-resistant mutations of SARS-CoV-2 papain-like protease
by: Haozhou Tan, et al.
Published: (2025-05-01)